Milling Research Published in NEJM

August 30, 2016

TJ MillingA research study co-authored by Emergency Service Partners physician Dr. T.J. Milling has been published in the New England Journal of Medicine. The article, titled “Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors,” appears in the August 30, 2016 issue.

The study reports interim results of an investigational drug, andexanet alfa, that works as an antidote to blood thinners known as Factor Xa inhibitors. If approved, the drug could be a potentially life-saving therapy for patients taking blood thinners who experience life-threatening bleeding.

“Currently, we have no way to turn off the anticoagulant action of these blood thinner drugs. Given these promising study findings, if you were in a car wreck and severely injured while taking a blood thinner, this could be the answer to help prevent you from bleeding out, if the drug is approved by the FDA,” Milling said.

Milling is listed as the second author of the study, but credits his ESP colleagues for their help.

“These studies would never work without the help of the emergency medicine physicians at Seton Medical Center Austin and University Medical Center Brackenridge,” Milling said. “They identify potential patients and call the study team. The study would fail without them.”

Read more about the study online.

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

About Emergency Service Partners, L.P.

Founded in 1988, Emergency Service Partners, L.P. is a physician practice management group specializing in hospital emergency departments (EDs). The physician-owned and physician-managed partnership serves more than 35 EDs across Texas. In addition, ESP provides pulmonary, intensive care, sleep medicine, hospitalist, and ob/gyn hospitalist services in Central Texas.